William Lay is an experienced cannabis executive.
He was the executive vice president of strategy, origination & operations at Creso Pharma in September 2021 before becoming group chief executive and managing director in January 2022.
Mr Lay began his career with leading Canadian full-service financial investment bank BMO Capital Markets, through roles across Canada and London. He then joined TSE- and NASDAQ-listed Canopy Growth Corporation as an M&A associate before being promoted to M&A associate director where he assessed and effected multiple transactions locally and internationally, while concurrently progressing corporate strategy initiatives across the group.
For over four years, Mr Lay has managed and supported over C$5 billion in cannabis M&A transactions, including leading the largest acquisition in the history of the cannabis sector.
